Importantly, these results were observed among a diverse and relevant population of hospitalized adults with T1D and T2D, full-dose insulin requirements, active clinical conditions, steroid use, long hospitalizations, and a range of prior home glucose control by HbA1c. The gene discussed is INS; the disease is type 2 diabetes mellitus.